LabBase Plus celebrates pride
Search
Click to replace search prompt
Cancel
  • Click to replace search prompt Search broadly for image detection job offers Click to replace search prompt
  • Click to replace search prompt I want to find companies developing LLM Click to replace search prompt
  • Click to replace search prompt I want to work in the medical field Click to replace search prompt
  • Click to replace search prompt Find jobs in consulting that utilizes data science and AI Click to replace search prompt

AI Scientist

HIROTSU BIO SCIENCE INC.

  • Salary ⁨¥⁩⁨4,000,000⁩ - ⁨6,000,000⁩
  • Company employee count 11 to 100

Job Summary

創りたい未来 N-NOSEは、ステージ０や１の初期の小さながんであっても線虫が反応することを利用した、世界初の全身網羅型がんスクリーニング検査サービスです。これまでのがん検査は体の異変があり、病院で受けることが当たり前でしたが、N-NOSEは未病の段階でがんのリスクを判定することができるのです。しかも、ご自宅で自分自身でそれを顕在化することができます。 リスクが低ければ、家族も自分も安心することができます。 もしリスクが高くても、健康に気を付けたり、より精密な検査を受けたりと、早い段階で対処ができ、その後の人生を選択することができます。 N-NOSEはすべての人の人生を豊かにします。今後、医療の発展により、ガンが発症する前に直せるようになったら、N-NOSEと医療で、私たちは全世界の命を救うことができるのです。 私たちが作るのは、 がんを怖れない世界 、そんな未来です。 Position and Work Environment HIROTSU BIO SCIENCE Inc. , the pioneering developer and provider of N-NOSE, the world's first primary screening cancer test using nematodes, is expanding its innovative research and development team at the Shonan R&D Center. We are seeking two exceptional PhD scientists to drive forward-thinking projects in wet and dry biology and to spearhead AI integration for evolving N-NOSE into advanced, precision multi-cancer early detection tools with US FDA approval. You'll focus on developing scalable data processing algorithms, machine learning models, and AI/ML-driven diagnostics to enhance cancer-type identification and screening accuracy, all while collaborating in our innovative, team-oriented lab. If you're passionate about blending biological expertise with cutting-edge computational tools to revolutionize early cancer detection, this is your opportunity to join a dynamic, collaborative environment that values creativity, initiative, and real-world impact. As a fast-rising company born from academic roots and achieving rapid growth, we stand apart from traditional Japanese firms by fostering an agile structure that encourages open dialogue, bold ideas, and swift decision-making. Our Chairman (former CEO) and the Founder, Dr. Takaaki Hirotsu, a scientist himself, leads alongside a diverse team of experts, sparking lively discussions to invent technologies that transform medicine and save lives. Here, you'll experience the full journey from lab discovery to global commercialization, with your contributions directly recognized through performance-based advancements, leadership opportunities, and

Company Info

HIROTSU BIO SCIENCE INC. is a Japanese healthcare company established in 2016, focused on developing and commercializing biological diagnostic technologies for early cancer detection. The company's primary product is the "N-NOSE" cancer screening test, which leverages the highly sensitive olfactory abilities of nematodes to detect minute scent substances in urine samples of cancer patients. This non-invasive test aims to provide a highly accurate, affordable, and comprehensive screening method for various types of cancer. The company also offers specialized tests like "N-NOSE plus" for specific cancers (e.g., pancreatic and liver cancer) and "N-NOSE animal" for pets. HIROTSU BIO SCIENCE is committed to making early cancer detection widely accessible globally and advancing research and development in biological diagnostics.

Login to see all information about offers.

By registering with LabBase Plus you...

Picture of search page on product

You can select from our vast stock of job offers.

  • Can view all curation offers.
  • Receive notifications of new offers added to curations.
  • Possibly be scouted by corporations.
  • Search for companies with unique technologies.
  • Search for job offers in areas like inorganic chemistry material science.

Registration takes roughly 2 minutes